To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Peter Kang Laboratory

Peter Kang, MD

Associate Professor of Medicine
Cardiovascular Research
Cardiovascular Division
Beth Israel Deaconess Medical Center
Boston MA 02215
Tel: 617-735-4290
Fax: 617-735-4202
e-mail: pkang@bidmc.harvard.edu

Education/Training/Appointments

Dr. Kang received his B.A. from the University of California at Berkeley, Berkeley, CA, and his M.D. from George Washington University School of Medicine, Washington, D.C. He completed an Internship and Residency at Albert Einstein College of Medicine in New York, and a Cardiology Fellowship at Beth Israel Hospital/Harvard Medical School, Boston, MA. He is currently a full-time cardiology faculty member at Beth Israel Deaconess Medical Center and an Associate Professor of Medicine at Harvard Medical School.

Kang Lab Members

Soochan Bae, PhD, Research Fellow
Byung Ryul Cho, MD, Research Fellow
Sylvia Singh, MD, Research Fellow
Qingen Ke, MD, Research Fellow
Mohammed Samad, MS, PhD Student
Ji Yoo (Sunny) Lee, BS, Research Assistant
Seung Gyu Park, BS, Research Student
On Hwang, BS, Research Student
Nam Eun (Faye) Min, BS, Research Student

Research Interests

The major focus of our laboratory is basic and translational cardiovascular research with an emphasis on developing novel therapies for cardiovascular diseases. One of our research interests is to study the molecular mechanisms of cardiac apoptosis and develop novel anti-apoptotic applications in cardiovascular diseases. Specifically, we are developing novel nanoparticle-based systems that are activated by hydrogen peroxide, the most abundant form of reactive oxygen species produced during reperfusion injury, to be used in cardiovascular therapeutics and bio-imaging.

In addition, we showed that Vitamin D therapy prevents the progression of cardiac hypertrophy and heart failure in animal models. We are currently investigating the molecular mechanism of cardiac dysfunction associated with Vitamin D deficiency and examining the potential role of Vitamin D therapy in the treatment of heart failure. Also, we, in collaboration with other investigators, identified novel VDR agonists and are studying these novel compounds for clinical applications.

Key Publications

Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, Pu WT, Kang PM. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 2006; 99:415-423.

Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi A, Thadhani R, Kang PM. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007; 104:16810-5.

Choudhury S, Bae S, Kumar SR, Ke Q, Yalamarti B, Choi JH, Kirshenbaum LA, Kang PM. Role of AIF in cardiac apoptosis in hypertrophic cardiomyocytes from Dahl salt sensitive rats. Cardiovasc Res 2010; 85:28-37.

Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011: 106:397-407.

Bae, S, Yalamarti B, Ke Q, Choudhury S, Karumanchi SA, Kroeger P, Thadhani R, Kang PM. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res 2011; 91:632-9.

Contact Information

Peter Kang Laboratory
Cardiovascular Institute
Beth Israel Deaconess Medical Center
3 Blackfan Circle, CLS-910
Boston, MA 02115
617-735-4290
617-735-4202
pkang@bidmc.harvard.edu